1. Home
  2. MVBF vs PEPG Comparison

MVBF vs PEPG Comparison

Compare MVBF & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

HOLD

Current Price

$25.28

Market Cap

329.1M

Sector

Finance

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.35

Market Cap

425.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVBF
PEPG
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
329.1M
425.1M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
MVBF
PEPG
Price
$25.28
$5.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$27.60
$11.67
AVG Volume (30 Days)
27.5K
585.3K
Earning Date
05-14-2026
06-08-2026
Dividend Yield
2.72%
N/A
EPS Growth
34.64
25.61
EPS
2.06
N/A
Revenue
$3,400,000.00
N/A
Revenue This Year
$1.28
N/A
Revenue Next Year
$13.59
N/A
P/E Ratio
$12.15
N/A
Revenue Growth
51.92
N/A
52 Week Low
$15.59
$0.89
52 Week High
$29.59
$7.80

Technical Indicators

Market Signals
Indicator
MVBF
PEPG
Relative Strength Index (RSI) 39.11 42.90
Support Level $25.24 $4.62
Resistance Level $27.15 $5.50
Average True Range (ATR) 0.78 0.59
MACD -0.16 -0.11
Stochastic Oscillator 25.66 14.90

Price Performance

Historical Comparison
MVBF
PEPG

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: